Validations: Serialization, Aggregation & Supply-Chain Data Integrity
Impact Assessment Trees: What to Verify vs Re-Validate Introduction to Impact Assessment in Serialization In the pharmaceutical industry, particularly within the domains of serialization and aggregation, the importance of rigorous validation processes cannot be overstated. Impact assessments serve as a critical component of these validation efforts, ensuring that systems and processes conform to regulatory standards such as the FDA, EMA,…
Test Packs for Changes: Regression, Interfaces, and Lines In the modern pharmaceutical industry, the need for robust serialization and aggregation systems has become paramount. Ensuring compliance with regulations such as the Drug Supply Chain Security Act (DSCSA) in the US and the EU Falsified Medicines Directive (FMD) is crucial to maintaining not only legal compliance but also data integrity and…
Master Data Changes: GTIN, GLN, SSCC, and Who Approves Master Data Changes: GTIN, GLN, SSCC, and Who Approves Introduction to Master Data Management in Serialization The implementation of serialization within the pharmaceutical supply chain requires rigorous management of master data, which encompasses Global Trade Item Numbers (GTIN), Global Location Numbers (GLN), and Serial Shipping Container Codes (SSCC). These elements ensure…
Partner On/Off-Boarding: Change Controls That Work In the pharmaceutical sector, ensuring robust serialization and aggregation processes is paramount for compliance with regulations such as the US Drug Supply Chain Security Act (DSCSA) and European Falsified Medicines Directive (FMD). A meticulous approach to change control during the on-boarding and off-boarding of partners serves as a cornerstone of maintaining data integrity and…
EPCIS Upgrades: 1.2→2.0—Evidence Expectations The evolution of the Electronic Product Code Information Services (EPCIS) from version 1.2 to 2.0 presents significant implications for the pharmaceutical industry, particularly concerning serialization and data integrity. As regulatory bodies such as the FDA, EMA, and MHRA intensify their focus on compliance with data integrity standards, understanding the latest updates and expectations associated with EPCIS…
Lessons from Regulator Warning Letters: A Step-by-Step Guide to Serialization and Aggregation Compliance Introduction to Serialization and Aggregation in Pharmaceutical Compliance In the pharmaceutical industry, adherence to serialization and aggregation regulations is critical for ensuring product integrity, patient safety, and regulatory compliance. Regulatory agencies such as the FDA, EMA, and MHRA have established stringent guidelines for serialization, which include unique…
Digital Dashboards for Audit/CAPA Introduction to Digital Dashboards in Pharmaceutical Validation In the rapidly evolving pharmaceutical landscape, ensuring compliance with regulatory frameworks such as the US FDA, EMA, and MHRA is paramount for quality assurance (QA) and quality control (QC) professionals. Digital dashboards are increasingly being recognized as essential tools for navigating the complexities associated with serialization/aggregation, especially in regard…
Peer Review Checklists for Investigations: A Comprehensive Guide Introduction to Serialization and Aggregation in Pharmaceutical Validation Serialization and aggregation are critical components in the pharmaceutical landscape, especially within the realms of supply chain integrity, regulatory compliance, and patient safety. As the industry continues to evolve, understanding the intricate nuances of these processes is essential for professionals engaged in pharmaceutical operations,…
Executive One-Pagers from Audit Trail Trends The rapid evolution of the pharmaceutical landscape obliges organizations to adapt and refine their serialization and aggregation practices. This guide details the essential framework for designing effective Serialization User Requirements Specifications (URS), interface validation, and the reconciliation of data, specifically targeting audit trails and investigations. Herein, you will find systematic steps that ensure compliance…
Change Documents Linked to Investigations Change Documents Linked to Investigations in Serialization and Aggregation In the pharmaceutical industry, effective serialization and aggregation processes are critical to ensuring compliance with regulatory standards and maintaining data integrity throughout the product lifecycle. This article serves as a comprehensive tutorial for pharmaceutical professionals, focusing on essential elements including User Requirement Specifications (URS), interface validation,…